Video summary

How Ancient Humans Got Blood Cancer (What Their Bones Reveal)

Main summary

Key takeaways

Science and Nature

Scientific concepts, discoveries, and nature/biological phenomena

Ancient evidence of cancer in bones (paleopathology)

  • Cancer is not modern: the video argues that what we now call blood cancers (e.g., leukemia and multiple myeloma) have biological roots in deep human history.

Swartkrans Cave tumor (South Africa)

  • In 1960, researchers examined a small foot bone from Swartkrans Cave (excavated since the 1940s).
  • The bone was about 1.7 million years old.
  • Finding: a tumor consistent with osteosarcoma, a cancer growing in bone tissue.
  • Claim: presented in the subtitles as one of the oldest known human-ancestor cases of cancer.

Bone marrow “factory” and how blood cancers arise

Bone marrow continuously produces blood (the video states “roughly a million new blood cells per minute”):

  • Red blood cells carry oxygen.
  • White blood cells fight threats.

Cancer mechanisms described

  • Leukemia
    • A cancer where white blood cells multiply uncontrollably.
    • Emphasis: leukemia typically does not leave durable bone lesions.
  • Multiple myeloma
    • A cancer of plasma cells (antibody-producing cells).
    • These cells “eat into” adjacent bone over time, producing:
      • bone destruction
      • holes.

Why multiple myeloma may be detectable in ancient remains

  • Bone lesions can persist for millennia.
  • The video describes diagnostic patterning in skeletal remains:
    • a pelvis/spine/skull fragment with small rounded pits (a pattern specialists recognize across skeletons).
  • Key methodological limitation: ancient diagnosis is probabilistic, not definitive:
    • no blood tests
    • no biopsy
    • no medical charts
    • no family history

Confounders

  • Tuberculosis can create lesions that can look similar on imaging.
  • Some metabolic disorders can also mimic the same bone pattern.

As a result, “probable myeloma” means it fits better than alternatives, not confirmation.

Why leukemia is hard to detect in ancient records

  • Leukemia lives in blood/soft tissues, which rarely survive long periods.
  • The closest surrogate evidence mentioned:
    • Harris lines: faint bands in long bones of children after growth pauses due to serious illness.
  • Limitation:
    • Harris lines indicate “major illness occurred,” but cannot reliably specify leukemia specifically.

The role of the fossil/archaeological record

The video stresses a sampling/visibility problem:

  • Only a tiny fraction of people leave remains that survive and are recovered.
  • Even fewer are examined with enough detail to detect lesions.

Core inference:

“Absence of evidence is not evidence of absence.”

Empty-looking records could reflect either:

  • disease absence, or
  • evidence not preserved/detected.

CT scanning mummies to search for soft-tissue evidence

  • Mummies can preserve soft tissue better than bare bones.
  • At the KNH Center for Biomedical Egyptology, scientists reportedly use CT scanning to look for:
    • tumors
    • organs
    • blood vessels
    • other tissue changes not visible in skeleton-only studies.

Evolutionary/anthropological explanation: why cancer may be undercounted in ancient populations

Proposed driver (per the video) is not that ancient people were more resistant, but that they lived shorter lives:

  • Blood cancers (leukemia/myeloma) build over long time through repeated errors in cell production.

Major competing causes in ancient life include:

  • infections
  • injuries
  • childbirth-related risks
  • starvation
  • exposure to harsh environments

Therefore, many people may have died before cancers developed fully, and even if cancer developed, it likely vanished without leaving evidence.

Modern cancer rate increases (age and exposure)

1994 study claim

  • A 1994 study argued ancient populations had much lower cancer rates than today.
  • Suggested modern factors:
    • diet
    • chemical exposures
    • and/or longer lifespan

Video’s main interpretation

  • Cancer risk is strongly age-dependent, especially for blood cancers.
  • Modern society may increase risk through:
    • increasing life expectancy (more time for mutations and cell-division errors)
    • increasing exposure to hazards (examples mentioned):
      • radiation
      • long-term benzene exposure

Main biological thesis stated:

  • The machinery for these cancers has been present for a very long time.
  • What changes is how long it can run and what it’s exposed to.

Medical context contrasted with the ancient record

Modern detection and treatment (as stated)

  • symptoms like persistent bruising, fatigue, pain
  • blood tests
  • bone marrow biopsy
  • ability to name conditions such as multiple myeloma

Prognosis contrast (as stated)

  • Ancient cases were often fatal within a couple years (for the diseases described).
  • Modern treatments can yield long survival times, including:
    • childhood leukemia survival rates above 90% for some forms (as claimed).

Researchers / sources featured (named in the subtitles)

  • Bruce Rothschild (spent decades developing/using the bone-lesion “vocabulary” for identifying probable myeloma in ancient remains)
  • A. Rosalie David (co-author of the 1994 analysis comparing ancient vs modern cancer rates)
  • Michael Zimmerman (co-author of the 1994 analysis)
  • KNH Center for Biomedical Egyptology (institutional source referenced for CT scanning of Egyptian mummies)

Original video